140 related articles for article (PubMed ID: 16397385)
1. Urinary transforming growth factor-beta1 in feline chronic renal failure.
Arata S; Ohmi A; Mizukoshi F; Baba K; Ohno K; Setoguchi A; Tsujimoto H
J Vet Med Sci; 2005 Dec; 67(12):1253-5. PubMed ID: 16397385
[TBL] [Abstract][Full Text] [Related]
2. Urinary active transforming growth factor β in feline chronic kidney disease.
Lawson JS; Syme HM; Wheeler-Jones CP; Elliott J
Vet J; 2016 Aug; 214():1-6. PubMed ID: 27387717
[TBL] [Abstract][Full Text] [Related]
3. Urinary transforming growth factor-beta 1 in various types of nephropathy.
De Muro P; Faedda R; Fresu P; Masala A; Cigni A; Concas G; Mela MG; Satta A; Carcassi A; Sanna GM; Cherchi GM
Pharmacol Res; 2004 Mar; 49(3):293-8. PubMed ID: 14726227
[TBL] [Abstract][Full Text] [Related]
4. Investigation of the transforming growth factor-beta 1 signalling pathway as a possible link between hyperphosphataemia and renal fibrosis in feline chronic kidney disease.
Lawson JS; Syme HM; Wheeler-Jones CPD; Elliott J
Vet J; 2021 Jan; 267():105582. PubMed ID: 33375963
[TBL] [Abstract][Full Text] [Related]
5. Steroid therapy and urinary transforming growth factor-beta1 in IgA nephropathy.
Haramaki R; Tamaki K; Fujisawa M; Ikedo H; Haramaki N; Okuda S
Am J Kidney Dis; 2001 Dec; 38(6):1191-8. PubMed ID: 11728950
[TBL] [Abstract][Full Text] [Related]
6. Profibrotic effects of angiotensin II and transforming growth factor beta on feline kidney epithelial cells.
van Beusekom CD; Zimmering TM
J Feline Med Surg; 2019 Aug; 21(8):780-787. PubMed ID: 30345862
[TBL] [Abstract][Full Text] [Related]
7. The cat as a naturally occurring model of renal interstitial fibrosis: Characterisation of primary feline proximal tubular epithelial cells and comparative pro-fibrotic effects of TGF-β1.
Lawson JS; Liu HH; Syme HM; Purcell R; Wheeler-Jones CPD; Elliott J
PLoS One; 2018; 13(8):e0202577. PubMed ID: 30138414
[TBL] [Abstract][Full Text] [Related]
8. Characterisation of feline renal cortical fibroblast cultures and their transcriptional response to transforming growth factor β1.
Lawson JS; Syme HM; Wheeler-Jones CPD; Elliott J
BMC Vet Res; 2018 Mar; 14(1):76. PubMed ID: 29523136
[TBL] [Abstract][Full Text] [Related]
9. Add-on angiotensin II receptor blockade lowers urinary transforming growth factor-beta levels.
Agarwal R; Siva S; Dunn SR; Sharma K
Am J Kidney Dis; 2002 Mar; 39(3):486-92. PubMed ID: 11877567
[TBL] [Abstract][Full Text] [Related]
10. Urinary transforming growth factor-beta1 excretion in renal allograft recipients during the early post-transplantation period.
Goumenos DS; Tsakas S; Karavias D; Savidaki I; Karatzas T; Vlachojannis JG
Ren Fail; 2003 Jul; 25(4):561-8. PubMed ID: 12911160
[TBL] [Abstract][Full Text] [Related]
11. Urinary cytokine levels in apparently healthy cats and cats with chronic kidney disease.
Habenicht LM; Webb TL; Clauss LA; Dow SW; Quimby JM
J Feline Med Surg; 2013 Feb; 15(2):99-104. PubMed ID: 22989558
[TBL] [Abstract][Full Text] [Related]
12. Effect of TGF-beta1 antisense oligodeoxynucleotide on renal function in chronic renal failure rats.
Hiong LC; Voon KL; Abdullah NA; Sattar MA; Rahman NA; Khan AH; Johns EJ
Acta Pharmacol Sin; 2008 Apr; 29(4):451-7. PubMed ID: 18358091
[TBL] [Abstract][Full Text] [Related]
13. Serum TGF-beta 1 and TNF-alpha levels and cardiac fibrosis in experimental chronic renal failure.
Fedulov AV; Ses TP; Gavrisheva NA; Rybakova MG; Vassilyeva JG; Tkachenko SB; Kallner A; MacMillan JC
Immunol Invest; 2005; 34(2):143-52. PubMed ID: 15921156
[TBL] [Abstract][Full Text] [Related]
14. Augmented cytoplasmic Smad4 induces acceleration of TGF-beta1 signaling in renal tubulointerstitial cells of hereditary nephrotic ICGN mice with chronic renal fibrosis; possible role for myofibroblastic differentiation.
Goto Y; Manabe N; Uchio-Yamada K; Yamaguchi-Yamada M; Inoue N; Yamamoto Y; Ogura A; Nagano N; Miyamoto H
Cell Tissue Res; 2004 Feb; 315(2):209-21. PubMed ID: 14615933
[TBL] [Abstract][Full Text] [Related]
15. Ureic clearance granule, alleviates renal dysfunction and tubulointerstitial fibrosis by promoting extracellular matrix degradation in renal failure rats, compared with enalapril.
Huang YR; Wei QX; Wan YG; Sun W; Mao ZM; Chen HL; Meng XJ; Shi XM; Tu Y; Zhu Q
J Ethnopharmacol; 2014 Sep; 155(3):1541-52. PubMed ID: 25087615
[TBL] [Abstract][Full Text] [Related]
16. Urinary Transforming Growth Factor-beta 1 as a marker of response to immunosuppressive treatment, in patients with crescentic nephritis.
Goumenos DS; Kalliakmani P; Tsakas S; Sotsiou F; Vlachojannis JG
BMC Nephrol; 2005 Dec; 6():16. PubMed ID: 16367998
[TBL] [Abstract][Full Text] [Related]
17. Increased urinary excretion of alpha1-microglobulin at 6 months after transplantation is associated with urinary excretion of transforming growth factor-beta1 and indicates poor long-term renal outcome.
Teppo AM; Honkanen E; Finne P; Törnroth T; Grönhagen-Riska C
Transplantation; 2004 Sep; 78(5):719-24. PubMed ID: 15371675
[TBL] [Abstract][Full Text] [Related]
18. Citrate attenuates tubulointerstitial fibrosis in 5/6 nephrectomized rats by decreasing transforming growth factor-beta1.
Manotham K; Eiam-Ong S; Eiam-Ong S; Wannakrairot P; Praditpornsilpa K; Chusil S; Tungsanga K
J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S168-77. PubMed ID: 17044470
[TBL] [Abstract][Full Text] [Related]
19. Impact of renal denervation on renal content of GLUT1, albuminuria and urinary TGF-beta1 in streptozotocin-induced diabetic rats.
D'Agord Schaan B; Lacchini S; Bertoluci MC; Irigoyen MC; Machado UF; Schmid H
Auton Neurosci; 2003 Mar; 104(2):88-94. PubMed ID: 12648610
[TBL] [Abstract][Full Text] [Related]
20. Acid-base balance of cats with chronic renal failure: effect of deterioration in renal function.
Elliott J; Syme HM; Markwell PJ
J Small Anim Pract; 2003 Jun; 44(6):261-8. PubMed ID: 12831103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
